199 related articles for article (PubMed ID: 37543674)
1. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
[TBL] [Abstract][Full Text] [Related]
2. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes.
Ren Y; He S; Feng S; Yang W
Front Public Health; 2022; 10():916364. PubMed ID: 35712285
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
4. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
5. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
Yang M; He H; Peng T; Lu Y; Yu J
Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
[TBL] [Abstract][Full Text] [Related]
6. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
Front Immunol; 2022; 13():959967. PubMed ID: 36177002
[TBL] [Abstract][Full Text] [Related]
7. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
[TBL] [Abstract][Full Text] [Related]
8. Construction of a prognostic model based on genes associated with mitochondrial energy metabolic pathway in colon adenocarcinoma and its clinical significance.
Zhang X; Liang C; Zhou B; Pang L
J Mol Recognit; 2023 Aug; 36(8):e3044. PubMed ID: 37322568
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy.
Huang X; Sun Y; Song J; Huang Y; Shi H; Qian A; Cao Y; Zhou Y; Wang Q
Front Immunol; 2023; 14():1301452. PubMed ID: 38045683
[TBL] [Abstract][Full Text] [Related]
10. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma.
Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A
Front Oncol; 2022; 12():941156. PubMed ID: 36505813
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment.
Huang D; Tang E; Zhang T; Xu G
Front Immunol; 2022; 13():916284. PubMed ID: 35860256
[TBL] [Abstract][Full Text] [Related]
12. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
Front Immunol; 2022; 13():881359. PubMed ID: 35911752
[TBL] [Abstract][Full Text] [Related]
13. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3.
Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J
Technol Cancer Res Treat; 2023; 22():15330338231195494. PubMed ID: 37650153
[No Abstract] [Full Text] [Related]
14. Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma.
Liu H; Zhang Y; Zhang Q; Zhang T; Lu T
Front Biosci (Landmark Ed); 2023 Dec; 28(12):328. PubMed ID: 38179743
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
Wang H; Wang W; Wang Z; Li X
Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
[TBL] [Abstract][Full Text] [Related]
16. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
17. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
Front Oncol; 2022; 12():876660. PubMed ID: 35747790
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic model for mitophagy-related genes in colon adenocarcinoma: A study based on TCGA and GEO databases.
Tang Y; Guo H; Chen L; Wang X; Chen Q; Gou L; Liu X; Wang X
PLoS One; 2023; 18(4):e0284089. PubMed ID: 37023088
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
[TBL] [Abstract][Full Text] [Related]
20. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
